Humacyte, Inc.
Moderate confidence (50%)
Updated Oct 12, 2026, 12:05 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: Humacyte, Inc. was delisted from its exchange (Aug 25, 2026)
Timeline
Every material event, newest first. History is never overwritten.
Humacyte, Inc. was delisted from its exchange
Aug 25, 2026
Delisting effective
- SEC EDGAR — “X0203 0001354457 Nasdaq Stock Market LLC 0001818382 Humacyte, Inc. 001-39532 2525 East North Carolina Highway 54 Durham NC NORTH CAROLINA 27713 (919) 313-9633 Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 17 CFR 240.12d2-2(a)(2) Tara Petta AVP 2026-08-25”
Humacyte, Inc. received a delisting notice from its exchange
Jul 31, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On July 31, 2026, Humacyte, Inc. (the Company ) received a letter from the staff (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) providing notification that, for the 30 consecutive business days ended July 30, 2026, the bid price for the Company s common stock, par value $0.0001 per share (the Common Stock ), had closed below the minimum $1.00 per share requirement for continued listing on The Nasdaq Global Select Market under Nasdaq Listing Rule 5450(a)(1). In accordance with N…”
Humacyte, Inc. received a delisting notice from its exchange
May 4, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On May 4, 2026, Humacyte, Inc. (the Company ) received a letter from the staff (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) providing notification that, for the 30 consecutive business days ended May 1, 2026, the bid price for the Company s common stock, par value $0.0001 per share (the Common Stock ), had closed below the minimum $1.00 per share requirement for continued listing on The Nasdaq Global Select Market under Nasdaq Listing Rule 5450(a)(1). In accordance with Nasda…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Biological Products, (No Diagnostic Substances)
- Subindustry
- —
- Listing
- SEC lists the tickers HUMA and HUMAW on Nasdaq.
- SEC CIK
- 0001818382
- Website
- —
- —
- Headquarters
- DURHAM
- Also known as
- Alpha Healthcare Acquisition Corp.
- Legal entities
- Humacyte, Inc.
Sources
Every material source used to build this profile.
SEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On May 4, 2026, Humacyte, Inc. (the Company ) received a letter from the staff (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) providing notification that, for the 30 consecutive business days ended May 1, 2026, the bid price for the Company s common stock, par value $0.0001 per share (the Common Stock ), had closed below the minimum $1.00 per share requirement for continued listing on The Nasdaq Global Select Market under Nasdaq Listing Rule 5450(a)(1). In accordance with Nasda…
View source recordSEC Company Submissions (TIER 1 · UNVERIFIED)
Humacyte, Inc. — Biological Products, (No Diagnostic Substances) (SIC 2836) — DURHAM, NC
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
X0203 0001354457 Nasdaq Stock Market LLC 0001818382 Humacyte, Inc. 001-39532 2525 East North Carolina Highway 54 Durham NC NORTH CAROLINA 27713 (919) 313-9633 Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 17 CFR 240.12d2-2(a)(2) Tara Petta AVP 2026-08-25
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On July 31, 2026, Humacyte, Inc. (the Company ) received a letter from the staff (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) providing notification that, for the 30 consecutive business days ended July 30, 2026, the bid price for the Company s common stock, par value $0.0001 per share (the Common Stock ), had closed below the minimum $1.00 per share requirement for continued listing on The Nasdaq Global Select Market under Nasdaq Listing Rule 5450(a)(1). In accordance with N…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:30 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:12 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:33 PM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 12, 2026, 12:04 AM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 11, 2026, 12:01 AM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:36 AM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:27 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.